STOCK TITAN

Varex Imaging (VREX) Stock News

VREX Nasdaq

Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.

Varex Imaging Corporation reports developments tied to its X-ray imaging component business, including X-ray tubes, digital detectors, connecting devices, imaging software and industrial X-ray systems. Company news commonly covers results from its Medical and Industrial segments, demand trends in CT products, cargo security systems and photon counting detectors, and updates for products used by global OEM manufacturers in medical, industrial and security imaging applications.

Recurring announcements also include earnings releases and conference calls, investor conference participation, and capital-structure actions such as the refinancing of secured debt and redemption of senior secured notes.

Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX) announced its upcoming participation in the Sidoti Small Cap Virtual Conference. The company's management team will deliver a presentation on Wednesday, September 17, 2025 at 3:15 PM ET. Investors can access the webcast through the provided link or via Varex's corporate website at vareximaging.com/news.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.44%
Tags
conferences
-
Rhea-AI Summary

Varex Imaging (NASDAQ: VREX) reported Q3 FY2025 financial results with revenues of $203 million, exceeding guidance but down 3% year-over-year. The company's Medical segment revenue decreased 4% to $142 million, while the Industrial segment revenue grew 1% to $61 million.

Non-GAAP gross margin improved to 34% from 32% in Q3 FY2024, with non-GAAP EPS increasing to $0.18 from $0.14. Operating cash flow was $8 million, with cash and equivalents at $153 million after paying down Convertible Notes. For Q4 FY2025, Varex expects revenues between $210-230 million and non-GAAP EPS of $0.10-0.30.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.38%
Tags
-
Rhea-AI Summary

Varex Imaging Corporation (Nasdaq: VREX), a leading manufacturer of X-ray imaging components, has scheduled its third quarter fiscal year 2025 earnings release and conference call. The company will announce its unaudited financial results on Thursday, August 7, 2025, after market close, followed by a conference call at 3:00 PM Mountain Time.

Investors can access the conference call via U.S. toll-free number (877-524-8416) or international number (412-902-1028). The webcast will be available on the company's investor relations website, with a replay accessible through August 21st using access code 13754994.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.36%
Tags
conferences earnings
Rhea-AI Summary

Varex Imaging (Nasdaq: VREX) has secured new orders worth $17 million for its high-energy non-intrusive cargo and vehicle inspection systems from international customers. The systems will be deployed at strategic sea and land ports for security purposes.

CEO Sunny Sanyal highlighted that the company's Cargo Systems business has received orders totaling over $55 million year-to-date, demonstrating Varex's strong position in high-energy Linear Accelerator based imaging technology and its integration capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.94%
Tags
none
-
Rhea-AI Summary

Varex Imaging Corporation (VREX) has announced its participation in the upcoming Jefferies Global Healthcare Conference in New York. The company's management team is scheduled to deliver a presentation on Wednesday, June 4, 2025, at 8:10 AM ET. Interested parties can access the webcast through a provided link or via Varex's official website at www.vareximaging.com/news.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
conferences
-
Rhea-AI Summary
Varex Imaging (NASDAQ: VREX) reported its Q2 FY2025 financial results with revenues of $213 million, up 3% year-over-year. The company achieved a GAAP gross margin of 36% and non-GAAP gross margin of 36%. Medical segment revenue reached $154 million (up 3%), while Industrial segment revenue was $59 million (up 3%). Non-GAAP EPS improved to $0.26 from $0.16 in Q2 FY2024. Cash flow from operations was $17 million, with cash and equivalents at $226 million. However, due to high Chinese tariffs on U.S. products causing customers to pause purchases, Varex reduced its Q3 FY2025 outlook, projecting revenues between $180-200 million and non-GAAP EPS between -$0.05 and $0.10. The company plans to repay its Convertible Notes due June 2025 at maturity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.46%
Tags
Rhea-AI Summary

Varex Imaging Corporation (VREX) has secured orders worth $25 million USD for its high-energy non-intrusive cargo and vehicle inspection systems from an international customer. The systems will be deployed at strategic sea and land ports for security purposes. CEO Sunny Sanyal highlighted the company's leadership in high-energy Linear Accelerator based imaging technology, emphasizing how their reputation for quality and excellence has helped secure new business in Cargo Systems.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.46%
Tags
none
-
Rhea-AI Summary

Varex Imaging (VREX) has announced it will release its unaudited financial results for the second quarter of fiscal year 2025 after market close on Thursday, May 8, 2025. The company will host a conference call at 3:00 pm Mountain Time on the same day.

Investors can participate through multiple channels: via webcast on the company's investor relations website, by calling 877-524-8416 (U.S.) or 412-902-1028 (international). A replay will be available from May 8th through May 22nd.

Varex is a leading manufacturer of X-ray imaging components and systems, with a 70+ year history in innovation. The company produces X-ray tubes, digital detectors, and imaging solutions for both medical and industrial applications, employing approximately 2,300 people across North America, Europe, and Asia.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.73%
Tags
conferences earnings
-
Rhea-AI Summary

Varex Imaging (VREX) has announced its upcoming participation in two major investor conferences in March 2025. The company will present at the Oppenheimer's 35th Annual MedTech & Services Virtual Conference on Monday, March 17, 2025, at 12:00 PM ET, followed by the Sidoti Small Cap Virtual Conference on Wednesday, March 19, 2025, at 12:15 PM ET.

Both presentations will be accessible via webcast through the provided links or through Varex's official website at vareximaging.com/news.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
conferences
Rhea-AI Summary

Varex Imaging (VREX) reported Q1 FY2025 financial results with revenues of $200 million, representing a 5% year-over-year increase. The Medical segment revenue grew 3% to $145 million, while the Industrial segment saw a 10% increase to $55 million.

The company achieved a GAAP gross margin of 34% and non-GAAP gross margin of 35%, with operating margins of 6% (GAAP) and 7% (non-GAAP). The quarter resulted in a GAAP net loss of $0.01 per diluted share, while non-GAAP earnings were $0.07 per share. Cash flow from operations was $10 million, with cash and equivalents reaching $219 million.

For Q2 FY2025, Varex expects revenues between $200-215 million and non-GAAP earnings per diluted share between $0.05-0.20.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.28%
Tags

FAQ

What is the current stock price of Varex Imaging (VREX)?

The current stock price of Varex Imaging (VREX) is $9.66 as of May 15, 2026.

What is the market cap of Varex Imaging (VREX)?

The market cap of Varex Imaging (VREX) is approximately 422.3M.